Professor of Medicine, University of Texas Health Science Center at Tyler
Pulmonology
Dr. William M. Girard, MD
|
|
Give Review
William Girard practices Pulmonology. He went to Louisiana State University School of Medicine in New Orleans. He over the years received 1 awards: "Meaningful Use Stage 1 Certification". William Girard is a published physician. He published 23 publications, including: 'Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negativ...' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor.
- Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium.
- Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular Bronchiectasis.
- Itraconazole therapy for blastomycosis and Histoplasmosis. NIAID Mycoses Study Group.
- Beta-Carotene, vitamin A, and Lung cancer chemoprevention: results of an intermediate endpoint study.
- A controlled trial of colchicine to reduce the elastase load in the lungs of cigarette smokers with Chronic obstructive pulmonary disease.
- Reduction of neutrophil elastase load in the Lungs of patients with emphysema by reducing neutrophil enzyme secretion or chemotaxis.
- Abnormalities of pathways of fibrin turnover in the human Pleural space.
- A controlled trial of colchicine to reduce the elastase load in the lungs of ex-cigarette smokers with Chronic obstructive pulmonary disease.
- Clarithromycin-induced hepatotoxicity.
- Clinical features of Pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients.
- Production of interleukin-18 in human tuberculosis.
- Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial Lung disease.
- Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex Lung disease.
- Azithromycin-containing regimens for treatment of Mycobacterium avium complex Lung disease.
- Azithromycin activity against Mycobacterium avium complex Lung disease in patients who were not infected with human immunodeficiency virus.
- Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex Lung disease.
- Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection.
- Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex Lung disease in human immunodeficiency virus-negativ...
- Clarithromycin regimens for Pulmonary Mycobacterium avium complex. The first 50 patients.
- Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex.
- Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex Lung disease.
Schools
Louisiana State Univ School Of Medicine In New Orleans
Meth Hospital
Charity Hospital
Confederate Meml Med Center
La St University
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Acute Pharyngitis
- Asbestosis
- Asthma
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Louisiana State University -
Louisiana State University School of Medicine in New Orleans
Drug Facts
| NPI NUMBER | 1871582270 | |
| NPPES Provider LastName | GIRARD | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 757083154 | |
| NPPES Provider State | TX | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 1719.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 15.0 | |
| Percent Opioid Claims | 0.87 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871582270 |
| Last Name Of The Provider | GIRARD |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. Arshad A. Abbasi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacy L. Retz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Varsha S. Taskar, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Steven Idell, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Wilbur G. Avery, MD |
|
|
Dr. George A. Hurst, MD |
|
|
Dr. Megan S. Devine, MD
This Doctor is OpenDoctor Recommended.
|